Caris Life Sciences Unveils the Next Evolution of Liquid Biopsy with Enhanced Caris Assure
Integrated DNA, RNA and Whole-Blood Analysis Provides Deeper Molecular Insights for Precision Oncology IRVING, Texas, Sept. 29, 2026 /PRNewswire/ -- Caris Life Sciences® (Caris), a leading AI TechBio company, today unveiled the enhanced Caris Assure®, a new evolution of liquid biopsy. By...